Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma

Nutrition

Volumn 14, Issue 2, 1998, Pages 165-172

  Weimann, Arved ^a   Bastian, Leonard ^a   Bischoff, Werner E ^a   Grotz, Martin ^a   Hansel, Matthias ^a   Lotz, Joachim ^a   Trautwein, Christian ^b   Tusch, Günter ^a   Schlitt, Hans J ^a   Regel, Gerd ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Arginine; Critically ill; Enteral nutrition; Immunonutrition; Omega 3 fatty acids; Trauma

Indexed keywords

ARGININE; NUCLEOTIDE; OMEGA 3 FATTY ACID;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DIET SUPPLEMENTATION; HUMAN; INFECTION RISK; INFLAMMATION; INJURY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; ARGININE; C-REACTIVE PROTEIN; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; MONOCYTES; MULTIPLE ORGAN FAILURE; NUCLEOTIDES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WOUNDS AND INJURIES;

EID: 6844251622     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(97)00429-2     Document Type: Article

References (39)

1. 1. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with patenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 1992;216:172
2. 2. European Society of Intensive Care Medicine. Round table conference on metabolic support of the critically ill patients - March 20-22, 1993. Intensive Care Med 1994;20:298
3. 3. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117
4. 4. Alexander JW. Immune enhancement via enteral nutrition. Arch Surg 1993;128:1242
5. 5. Cynober L. Can arginine and ornithine support gut functions? Gut 1994;35(suppl 1):S42
6. 6. Barbul A. Arginine and immune function. Nutrition 1990;6:53
7. 7. Reynolds JV, Daly JM, Shou JL, et al. Immunologic effects of arginine supplementation in tumour-bearing and non-tumor-hosts. Ann Surg 1990;211:202
8. 8. Billiar TR. Nitric oxide. Novel biology with clinical significance. Ann Surg 1995;221:339
9. 9. Rodeberg DA, Chaet MS, Bass RC, et al. Nitric oxide: an overview. Am J Surg 1995;170:292
10. 10. Fukatsu K, Saito H, Fukushima R, et al. Detrimental effects of a nitric oxidase synthase inhibitor (N-omega-nitro-L-arginine methyl-ester) in a murine sepsis model. Arch Surg 1995;130:410
11. 11. Kinsella JE, Lokesh B, Broughzon S, et al. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 1990;6:24
12. 12. Gottschlich MM. Selection of optimal lipid sources in enteral and parenteral nutrition. Nutr Clin Pract 1992;7:152
13. 13. Rudolph FB, Kulkarni AD, Fanslow WC, et al. Role of RNA as a dietary source of pyrimidines and purines in immune function. Nutrition 1990;6:45
14. 14. Grimble GK. Dietary nucleotides and gut defence. Gut 1994;35(suppl 1):S46
15. 15. Daly JM, Liebermann MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, omega-3 fatty acids in patients after operation: immunologic, metabolic and clinical outcome. Surgery 1992;112:56
16. 16. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective randomized clinical trial. Crit Care Med 1995;23:436
17. 17. Braga M, Vignali A, Gianotti L, et al. Benefits of early postoperative enteral feeding in cancer patients. Infusionsther Transfusionsmed 1995;22:280
18. 18. Kemen M, Senkal H, Homann HH, et al. Early postoperative enteral nutrition with arginine-omega-3-fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients. An immunologic evaluation of Impact. Crit Care Med 1995;23:652
19. 19. Daly JM, Weintraub FN, Shou J, et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995;221:327
20. 20. Baker SP, O'Neill B. The injury severity score: an update. J Trauma 1976;16:882
21. 21. Committee on Medical Aspects of Automotive Safety. Rating the severity of tissue damage. I. The abreviated scale. JAMA 1971;215: 277
22. 22. Regel G, Lobenhoffer P, Grotz M, et al. Treatment results of patients with multiple trauma: An analysis of 3406 cases treated between 1972 and 1991 at a German level I trauma center. J Trauma 1995;38:70
23. 23. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818
24. 24. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864
25. 25. Sauaia A, Moore FA, Moore EE, et al. Early predictor of postinjury multiple organ failure. Arch Surg 1994;129:39
26. 26. CDC Definitions of nosocomial infections. In: Mayhall CG, ed. Hospital epidemiology and infection control. Baltimore: Williams & Wilkins, 1996:App-A-4
27. 27. Schlitt HJ, Raddatz G, Steinhoff G, et al. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation 1993;56:951
28. 28. Moore EE, Moore FA, Franciose RJ, et al. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 1994;37:881
29. 29. Regel G, Grotz M, Weltner T, et al. Pattern of organ failure following severe trauma. World J Surg 1996;20:422
30. 30. Bastian L, Weimann A, Regel G, et al. Feasibility and complications of early enteral nutrition in severely injured patients via nasoduodenal feeding tubes. Unfallchirurg 1996;99:642
31. 31. Souba WW. Nutritional support. New Engl J Med 1997;336:41
32. 32. Atkinson S, Sieffert E, Bihari D, et al. A randomised controlled clinical trial of the enteral immunonutrition. "Impact" in the critically ill. Intensive Care Med 1996;22(suppl 3):S351
33. 33. Senkal M, Kemen M, Homann HH, et al. Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995;161:115
34. 34. Cheadle WG, Hershman MJ, Wellhausen SR, et al. HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 1991;161:639
35. 35. Potgieter PD, Linton DM, Oliver S, et al. Nosocomial infections in a respiratory intensive care unit. Crit Care Med 1987;15:495
36. 36. Moore FA, Moore EE, Kudsk KA, et al. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994;37:607
37. 37. Kudsk KA, Minard G, Croce MA, et al. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg 1996;224:531
38. 38. Heyland DK, Cook DJ, Guyatt GH. Does the formulation of enteral feeding products influence infectious morbidity and mortality rates in the critically ill patient? A critical review of the evidence. Crit Care Med 1994;22:1192
39. 39. Kenler AS, Swails WS, Driscoll DF, et al. Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Ann Surg 1996;223:316